Yiheng Capital Management Portfolio holdings
Top Buys
| 1 |
TAL Education Group
TAL
|
+$79.4M |
| 2 |
ACM Research
ACMR
|
+$69.6M |
| 3 |
GBIO
Generation Bio
GBIO
|
+$42.4M |
| 4 |
JOYY
JOYY Inc
JOYY
|
+$39.3M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$34.6M |
Top Sells
Sector Composition
| 1 | Communication Services | 25.9% |
| 2 | Technology | 20.88% |
| 3 | Consumer Discretionary | 18.32% |
| 4 | Financials | 12.87% |
| 5 | Industrials | 8.6% |
Similar funds
Yiheng Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Yiheng Capital Management held 32 positions worth $2.48B, up 13% from $2.2B the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Yiheng Capital Management deployed $348M of net new capital in Q2 2021, opening 6 new positions and adding to 9 existing holdings. Its largest new stake was ACM Research: 2,532,600 shares worth $86.3M.
By sector, the portfolio is most concentrated in Communication Services at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was New Frontier Health Corporation Ordinary Shares, an estimated $15.7M trimmed.
- Yiheng Capital Management's largest Q2 2021 buy was ACM Research: 2,532,600 shares worth $86.3M.
- Yiheng Capital Management added most to TAL Education Group in Q2 2021, an estimated $79.4M increase.
- Yiheng Capital Management's biggest Q2 2021 reduction was New Frontier Health Corporation Ordinary Shares, cutting an estimated $15.7M.
- Yiheng Capital Management fully exited BILL Holdings in Q2 2021, selling an estimated $14.8M.
- Yiheng Capital Management's ten largest holdings make up 83% of its $2.48B portfolio in Q2 2021.
- Yiheng Capital Management opened 6 new positions and closed 4 in Q2 2021.
- Yiheng Capital Management's portfolio value rose 13% quarter-over-quarter to $2.48B.
Based on Yiheng Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.